Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11670116 | 1.00 | L3MBTL1 (0.49) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| SCHEMBL1446472 | 0.98 | TSHR (0.47) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| Hydrochloric Acid SCHEMBL344831 | 0.96 | TSHR (0.46) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| Bromide SCHEMBL12465741 | 0.96 | TSHR (0.46) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| SCHEMBL34585 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL344817 | 0.89 | TSHR (0.52) | TSHRKMT2ACYP1A2CHRM2CHRM4 | |
| SCHEMBL3512713 | 0.88 | L3MBTL1 (0.46) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| SCHEMBL1447146 | 0.86 | TSHR (0.44) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| SCHEMBL11670561 | 0.85 | L3MBTL1 (0.44) | L3MBTL1TSHRHRH3KMT2ACYP1A2 | |
| Hydrochloric Acid SCHEMBL4056528 | 0.84 | TSHR (0.43) | L3MBTL1TSHRHRH3KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | L3MBTL1 2569/4885TSHR 1902/4885HRH3 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.